As of 2025-12-14, the Relative Valuation of TherapeuticsMD Inc (TXMD) is 0.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.75 USD, the upside of TherapeuticsMD Inc based on Relative Valuation is -56.1%.
The range of the Relative Valuation is 0.37 - 1.06 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 37.8x | 26.0x |
| Forward P/E multiples | 25.0x - 40.5x | 32.8x |
| Fair Price | 0.37 - 1.06 | 0.77 |
| Upside | -78.6% - -39.7% | -56.1% |
| Date | P/E |
| 2025-12-08 | 63.60 |
| 2025-12-05 | 66.66 |
| 2025-12-04 | 61.68 |
| 2025-12-03 | 60.91 |
| 2025-12-02 | 55.93 |
| 2025-12-01 | 58.23 |
| 2025-11-28 | 65.13 |
| 2025-11-26 | 63.21 |
| 2025-11-25 | 62.06 |
| 2025-11-24 | 62.83 |
| 2025-11-21 | 68.19 |
| 2025-11-20 | 73.56 |
| 2025-11-19 | 63.21 |
| 2025-11-18 | 59.00 |
| 2025-11-17 | 58.23 |
| 2025-11-14 | 75.09 |
| 2025-11-13 | 62.06 |
| 2025-11-12 | 64.36 |
| 2025-11-11 | 62.64 |
| 2025-11-10 | 51.72 |
| 2025-11-07 | 53.25 |
| 2025-11-06 | 48.66 |
| 2025-11-05 | 45.59 |
| 2025-11-04 | 44.82 |
| 2025-11-03 | 44.06 |
| 2025-10-31 | 45.59 |
| 2025-10-30 | 47.51 |
| 2025-10-29 | 46.36 |
| 2025-10-28 | 47.89 |
| 2025-10-27 | 50.19 |
| 2025-10-24 | 49.42 |
| 2025-10-23 | 50.19 |
| 2025-10-22 | 46.74 |
| 2025-10-21 | 44.82 |
| 2025-10-20 | 44.06 |
| 2025-10-17 | 47.89 |
| 2025-10-16 | 40.04 |
| 2025-10-15 | 39.84 |
| 2025-10-14 | 39.84 |
| 2025-10-13 | 40.22 |
| 2025-10-10 | 39.84 |
| 2025-10-09 | 40.61 |
| 2025-10-08 | 40.61 |
| 2025-10-07 | 41.38 |
| 2025-10-06 | 40.23 |
| 2025-10-03 | 41.08 |
| 2025-10-02 | 40.61 |
| 2025-10-01 | 40.61 |
| 2025-09-30 | 41.18 |
| 2025-09-29 | 41.38 |